• OPEN AN ACCOUNT
Indian Indices
Sensex
82,532.19 427.40
( 0.52%)
Global Indices
Nasdaq
51,667.44 -701.11
(-1.34%)
Dow Jones
7,446.91 -135.76
(-1.79%)
Hang Seng
58,984.34 -677.68
(-1.14%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
94.26 0.34
(0.36%)
EUR-INR
103.88 -0.12
(-0.12%)
GBP-INR
124.50 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.38%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
686.0527542
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
36.31
55758.82
EPS(TTM)
Face Value()
Div & Yield %
93.05
1
0.59
 

Mahindra & Mahindra consolidated net profit rises 24.90% in the September 2026 quarter
Nov 05,2026
Net profit of Mahindra & Mahindra rose 24.90% to Rs 4587.88 crore in the quarter ended September 2026 as against Rs 3673.32 crore during the previous quarter ended September 2025. Sales rose 25.34% to Rs 57514.98 crore in the quarter ended September 2026 as against Rs 45885.40 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales57514.9845885.40 25
OPM %17.7719.48 -
PBDT9196.587737.64 19
PBT7364.706068.75 21
NP4587.883673.32 25